Bumetanide Injection
Mullan Pharmaceutical Inc.
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 12/13/2017
- Change date
- 09/30/2026
- Package NDC
- 83301-0081-2
- Generic name
- Bumetanide Injection
- Contact info
- 800-673-9839
- Resolved note
- Available
- Update date
- 09/30/2026
- Dosage form
- Injection
- Presentation
- Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)
- Company name
- Mullan Pharmaceutical Inc.
- Status
- Resolved
- Therapeutic category
- Cardiovascular
- Harmonized identifiers (openFDA)
- Application number
- ANDA219116
- Brand name
- BUMETANIDE
- Generic name
- BUMETANIDE
- Manufacturer name
- Mullan Pharmaceutical Inc.
- Product NDC
- 83301-0081, 83301-0080
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Substance name
- BUMETANIDE
- RxCUI
- 282486, 1727569
- SPL ID
- 4c241a3e-649b-4414-e063-6294a90a3a32
- SPL set ID
- b7cd724b-817b-4b45-8133-1ebf505867e7
- Package NDC
- 83301-0080-1, 83301-0080-2, 83301-0081-1, 83301-0081-2
- Nui
- N0000175366, N0000175590
- Pharm class pe
- Increased Diuresis at Loop of Henle [PE]
- Pharm class epc
- Loop Diuretic [EPC]
- UNII
- 0Y2S3XUQ5H
